Is Anteris Technologies Ltd a good investment? Anteris Technologies Ltd (AVR.AX) is currently trading at 11.68 AUD.
Earnings Schedule: Anteris Technologies Ltd is expected to release its next earnings report on Aug. 17, 2026. The market consensus estimate for Forward EPS is -2.17.
No, it does not currently pay a dividend.
Anteris Technologies Ltd is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Aug. 17, 2026. The company currently has a trailing EPS of -2.75.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
| Split Date | Split Ratio to 1 |
|---|---|
| Feb. 23, 2009 | 1.21 |
| Sept. 25, 2013 | 1.06 |
| March 24, 2015 | 1.02 |
| Nov. 17, 2015 | 1:10 |
| March 2, 2020 | 1:100 |
| March 12, 2020 | 1:100 |
Community Discussion